Health Canada Rejects Suffixes in Biologics Naming, Leaving the FDA Alone in the Practice

Drug Industry Daily
A A
Canada has opted not to use four-digit suffixes in its naming conventions for biologics, making the United States the convention’s only adherent.

To View This Article:

Login

Subscribe To Drug Industry Daily